References
  1. Fritsch P, Schwinger W, Schwantzer G, Lackner H, Sovinz P, Wendelin G, Benesch M, Sipurzynski S, Urban C. Peripheral blood stem cell mobilization with pegfilgrastim compared to filgrastim in children and young adults with malignancies. Pediatr Blood Cancer 2010;54:134-7.
  2. Cesaro S, Tintori V, Nesi F, Schiavello E, Calore E,  Dallorso S, Migliavacca M,  Capolsini I, Desantis R, Caselli D, Fagioli F, Luksch R, Panizzolo I, Tridello G,  Prete A. A prospective study on the efficacy of mobilization of autologous peripheral stem cells in pediatric oncohematology patients. Transfusion 2013 Jul;53(7):1501-9.
  3. Duong HK, Savani BN, Copelan E, Devine S, Costa LJ, Wingard JR, Shaughnessy P, Majhail N, Perales MA, Cutler CS, Bensinger W, Litzow MR, Mohty M, Champlin RE, Leather H, Giralt S, Carpenter PA. Peripheral blood progenitor cell mobilization for autologous and allogeneic hematopoietic cell transplantation: guidelines from the American Society for Blood and Marrow Transplantation. Biol Blood Marrow Transplant. 2014 Sep;20(9):1262-73.
  4. Baldomero H, Gratwohl M, Gratwohl A, Tichelli A, Niederwieser D, Madrigal A, Fraundorfer K. The EBMT activity survey 2009: trends over the past five years. Bone MarrowTransplant 2011;46:485-501.
  5. Pierelli L, Perseghin P, Marchetti M, Accorso P, Fanin R, Messina C, Olivieri A, Risso M, Salvaneschi L. Bosi A for Società Italiana di Emaferesi and manipolazione Cellulare (SIDEM) and Gruppo Italiano Trapianto di midollo Osseo (GITMO). Best practice for peripheral blood progenitor cell mobilization and collection in adults and children: results of a Società Italiana Di Emaferesi e Manipolazione Cellulare (SIDEM) and Gruppo Italiano Trapianto Midollo Osseo (GITMO) consensus process. Transfusion 2012;52: 893-905.
  6. Cesaro S, Zanazzo AG, Frenos S, Luksch R, Pegoraro A, Tridello G, Dallorso S. A Phase II study on the safety and efficacy of a single dose of pegfilgrastim for mobilization and transplantation of autologous hematopoietic stem cells in pediatric oncohematology patients. Transfusion 2011;51:2480-7.
  7. Arvedson T, O’Kelly J, Yang BB. Design Rationale and Development Approach for Pegfilgrastim as a Long-Acting Granulocyte Colony-Stimulating Factor. BioDrugs. 2015 Jun;29(3):185-98. doi: 10.1007/s40259-015-0127-4.
  8. Mishra P, Nayak B, Dey RK. PEGylation in anti-cancer therapy: An overview. Asian journal of pharmaceutical s c i e n c e s ( 2 0 1 6 ) 337–348
  9. Kuan JW, Su AT, Leong CF. Pegylated granulocyte-colony stimulating factor versus non-pegylated granulocyte-colony stimulating factor for peripheral blood stem cell mobilization: A systematic review and meta-analysis. J Clin Apher 2017 Dec;32(6):517-542.
  10. Wendelin G, Lackner H, Schwinger W, et al. Once-per-cycle Pegfilgrastim versus daily Filgrastim in pediatric patients with Ewing sarcoma. J Pediatr Hematol Oncol 2005;27:449–451.
  11. te Poele EM, Kamps WA, Tamminga RY, et al. Pegfilgrastim in pedaitric cancer patients. J Paediatr Hematol Oncol 2005;27:627–629.
  12. Andre N, Kababri ME, Bertrand P, et al. Safety and efficacy of PegFilgrastim in children with cancer receiving myelosuppressive chemotherapy. J Clin Oncol 2000;18:2522–2528.
  13. Fox E, Widemann BC, Hawkins DS, Jayaprakash N, Dagher R, Aikin AA, Bernstein D, Long L, Mackall C, Helman L, Steinberg SM, Balis FM. Randomized trial and pharmacokinetic study of pegfilgrastim versus filgrastim after dose-intensive chemotherapy in young adults and children with sarcomas. Clin Cancer Res. 2009 Dec 1;15(23):7361-7.
  14. Cesaro S, Nesi F, Tridello G, Abate M, Panizzolo IS, Balter R, Calore E. A randomized, non-inferiority study comparing efficacy and safety of a single dose of pegfilgrastim versus daily filgrastim in pediatric patients after autologous peripheral blood stem cell transplant. PLoS One. 2013;8(1):e53252.
  15. Dallorso S, Berger M, Caviglia I, Emanueli T, Faraci M, Scarso L, Fagioli F, Haupt R. Prospective single-arm study of pegfilgrastim activity and safety in children with poor risk malignant tumours receiving chemotherapy. Bone Marrow Transplant 2008;42:507-13.
  16. Merlin E, Zohar S, Jérôme C, Veyrat-Masson R, Marceau G, Paillard C, Auvrignon A, Le Moine P, Gandemer V, Sapin V, Halle P, Boiret-Dupré N, Chevret S, Deméocq F, Dubray C, Kanold J. Hematopoietic progenitor cell mobilization and harvesting in children with malignancies: do the advantages of pegfilgrastim really translate into clinical benefit? Bone Marrow Transplant 2009;43:919-25.
  17. Carter T, Jensen J, Baker D, Cole G. Use of Pegylated Granulocyte Colony Stimulating Factor Mobilisation for Autologous Peripheral Blood Stem Cell Rescue- A Paediatric Experience J Pediatr Hematol Oncol _ Volume 27, Number 9, September 2005.